• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Learning Objectives, Psychotic Depression, TCPR, June/July 2022

Learning Objectives, Psychotic Depression, TCPR, June/July 2022

June 1, 2022
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

After reading these articles, you should be able to:

  1. Evaluate the efficacy of quetiapine to prevent and treat bipolar depression.
  2.  Describe how to diagnose psychotic depression.
  3. Identify appropriate clinical scenarios for benzodiazepines.
  4. Summarize some of the current research findings on psychiatric treatment.


    www.thecarlatreport.com
    Issue Date: June 1, 2022
    SUBSCRIBE NOW
    Table Of Contents
    Quetiapine Reconsidered
    Psychosis During Depression
    Can TMS Turn on the Switch?
    Uncommon Tips: Which Is Better—Citalopram or Escitalopram?
    Benzodiazepines: A Reevaluation of Their Benefits and Dangers
    How Essential Is Antidepressant Continuation?
    Hypothyroidism and Depression: Just How Related Are They?
    Topiramate Improves Weight in Schizophrenia in South Asians
    CME Post-Test - Psychotic Depression, TCPR, June/July 2022
    DOWNLOAD NOW
    Featured Book
    • AUDFB1e_CoilBound_Graphic2_transparent_sm.png

      Treating Alcohol Use Disorder: A Fact Book (2023)

      All the tools and information needed to assess and treat your patients who are struggling with...
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto22709844.jpg
      General Psychiatry

      Psychopharm Commandment #10: Don’t Fear these Meds

      Surprising health benefits of our riskiest meds: Lithium, quetiapine, and clozapine.

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.